← SynDRA
ANECORTAVE ACETATE
SynDRA canonical compound SYN0032290 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Mechanism of action | angiogenesis inhibitor |
|---|
| Indication | macular degeneration |
|---|
| Disease area | ophthalmology |
|---|
All known targets
Mechanisms of action (all sources)
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- NR3C1
- ESR1
- HTR1A
- HTR2B
- HTR2C
- HTR3A
- KCNH2
- MAOA
- MC3R
- MC4R
- MLNR
- NPY1R
- NR1I2
- ADORA1
- OPRD1
- OPRK1
- OPRM1
- PDE3A
- PDE4D
- PGR
- PTGS2
- SLC29A1
- SLC6A2
- SLC6A3
- SLC6A4
- HTR2A
- HRH3
- ADORA2A
- BDKRB2
- ADORA3
- ADRA1A
- ADRA2A
- ADRA2B
- ADRA2C
- ADRB1
- ADRB2
- AGTR1
- AVPR1A
- AVPR2
- CCKAR
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
Drug classes
- Angiogenesis Inhibitors
- Antineoplastic Agents
- Growth Inhibitors
- Growth Substances
ATC classes
- S01L · OCULAR VASCULAR DISORDER AGENTS
Cross-references
Synonyms
- anecortave
- retaane
- Anecortave
- Anecortava
- Anecortave (usan)
- Anecortave desacetate
- AL-3789
- AL-4940
- AL3789
- AL4940
- NSC-15475
- NSC-24345
- Retaane (TN)
- ANECORTAVE
- Al 3789
- NSC 15475
- NSC 24345
- Y0PC411K4T
- DTXCID3026805
- 4,9(11)-pregnadien-17alpha,21-diol-3,20-dione-21-acetate
- RefChem:558056
- Retaane
- Anecortave acetate [USAN]
- Anecortave [INN]
- ANECORTAVE ACETATE F0E2980.997MG/MG(AI)
- Retaane suspension
- UNII-Y0PC411K4T
- NCGC00181018-01
- EINECS 231-812-5
- Anecortave acetate/H6
- ANECORTAVE [MART.]
- SCHEMBL94110
- orb1306352
- ANECORTAVE ACETATE [MI]
- Anecortave acetate (JAN/USAN)
- ANECORTAVE ACETATE [JAN]
- CHEBI:31215
Look up ANECORTAVE ACETATE in the interactive SynDRA portal →